BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 22871543)

  • 1. Critical pathogenic events underlying progression of neurodegeneration inĀ glaucoma.
    Calkins DJ
    Prog Retin Eye Res; 2012 Nov; 31(6):702-19. PubMed ID: 22871543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive responses to neurodegenerative stress in glaucoma.
    Calkins DJ
    Prog Retin Eye Res; 2021 Sep; 84():100953. PubMed ID: 33640464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma.
    Cooper ML; Crish SD; Inman DM; Horner PJ; Calkins DJ
    Exp Eye Res; 2016 Sep; 150():22-33. PubMed ID: 26646560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma.
    Maddineni P; Kasetti RB; Patel PD; Millar JC; Kiehlbauch C; Clark AF; Zode GS
    Mol Neurodegener; 2020 Aug; 15(1):48. PubMed ID: 32854767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axogenic mechanism enhances retinal ganglion cell excitability during early progression in glaucoma.
    Risner ML; Pasini S; Cooper ML; Lambert WS; Calkins DJ
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2393-E2402. PubMed ID: 29463759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection.
    Ward NJ; Ho KW; Lambert WS; Weitlauf C; Calkins DJ
    J Neurosci; 2014 Feb; 34(9):3161-70. PubMed ID: 24573275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distal axonopathy with structural persistence in glaucomatous neurodegeneration.
    Crish SD; Sappington RM; Inman DM; Horner PJ; Calkins DJ
    Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5196-201. PubMed ID: 20194762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric.
    Schlamp CL; Li Y; Dietz JA; Janssen KT; Nickells RW
    BMC Neurosci; 2006 Oct; 7():66. PubMed ID: 17018142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy.
    Nickells RW; Howell GR; Soto I; John SW
    Annu Rev Neurosci; 2012; 35():153-79. PubMed ID: 22524788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss.
    Soto I; Pease ME; Son JL; Shi X; Quigley HA; Marsh-Armstrong N
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):434-41. PubMed ID: 20811062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma.
    Howell GR; Libby RT; Jakobs TC; Smith RS; Phalan FC; Barter JW; Barbay JM; Marchant JK; Mahesh N; Porciatti V; Whitmore AV; Masland RH; John SW
    J Cell Biol; 2007 Dec; 179(7):1523-37. PubMed ID: 18158332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychophysical testing in rodent models of glaucomatous optic neuropathy.
    Grillo SL; Koulen P
    Exp Eye Res; 2015 Dec; 141():154-63. PubMed ID: 26144667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Glaucomatous Optic Neuropathy: The Synergy Between Clinical Observation and Investigation.
    Quigley HA
    Annu Rev Vis Sci; 2016 Oct; 2():235-254. PubMed ID: 28532352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatiotemporal characterization of optic nerve degeneration after chronic hypoperfusion in the rat.
    Chidlow G; Holman MC; Wood JP; Casson RJ
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1483-97. PubMed ID: 19875659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial coverage in the optic nerve expands in proportion to optic axon loss in chronic mouse glaucoma.
    Bosco A; Breen KT; Anderson SR; Steele MR; Calkins DJ; Vetter ML
    Exp Eye Res; 2016 Sep; 150():34-43. PubMed ID: 26851485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some current ideas on the pathogenesis and the role of neuroprotection in glaucomatous optic neuropathy.
    Osborne NN; Chidlow G; Wood J; Casson R
    Eur J Ophthalmol; 2003 Apr; 13 Suppl 3():S19-26. PubMed ID: 12749673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A broad perspective on the molecular regulation of retinal ganglion cell degeneration in glaucoma.
    Tezel G
    Prog Brain Res; 2020; 256(1):49-77. PubMed ID: 32958215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage.
    Morgan JE
    Eye (Lond); 2000 Jun; 14 ( Pt 3B)():437-44. PubMed ID: 11026971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria.
    Kimball EC; Pease ME; Steinhart MR; Oglesby EN; Pitha I; Nguyen C; Quigley HA
    Exp Eye Res; 2017 Jul; 160():106-115. PubMed ID: 28414059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss.
    Nuschke AC; Farrell SR; Levesque JM; Chauhan BC
    Exp Eye Res; 2015 Dec; 141():111-24. PubMed ID: 26070986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.